Direct effects of adriamycin on the rat heart sarcolemma.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Research communications in chemical pathology and pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 6142511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calcium movements in relation to heart function

  1982cited by this paper
• Ca2+- and Mg2+-dependent ATPase activities in the deoxycholate-treated rat heart sarcolemma.

  1982cited by this paper
• Purification and characterization of a Ca2+-dependent ATPase from rat heart sarcolemma.

  1982cited by this paper
• Solubilization of a calcium dependent adenosine triphosphatase from rat heart sarcolemma.

  1981cited by this paper
• The cardiotoxic antibiotic doxorubicin inhibits the Na+/Ca2+ exchange of dog heart sarcolemmal vesicles

  1981cited by this paper
• Anthracycline-associated cardiac and renal damage in rabbits. Evidence for mediation by vasoactive substances.

  1981cited by this paper
• Adriamycin Cardiotoxicity: possible pathogenic mechanisms.

  1981cited by this paper
• Inhibition of sodium-potassium-activated adenosine 5'-triphosphatase and ion transport by adriamycin.

  1979cited by this paper
• Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response.

  1977cited by this paper
• Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation.

  1977cited by this paper
• Reduction by coenzyme Q10 of the acute toxicity of adriamycin in mice.

  1977cited by this paper
• Adriamycin: energy metabolism and mitochondrial oxidations in the heart of treated rabbits.

  1976cited by this paper
• Adriamycin-a review.

  1975cited by this paper
• Alterations in DNA synthesis in cardiac tissue induced by adriamycin in vivo-relationship to fatal toxicity.

  1975cited by this paper
• Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.

  1974cited by this paper
• A clinicopathologic analysis of adriamycin cardiotoxicity

  1973cited by this paper
• Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells.

  1971cited by this paper
• Adenyl cyclase in cardiac tissue.

  1970cited by this paper
• A microcolorimetric method for the determination of inorganic phosphorus.

  1953cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• HSP27 role in cardioprotection by modulating chemotherapeutic doxorubicin-induced cell death

  2021cites this paper
• Attenuation of doxorubicin-induced cardiotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens.

  2021cites this paper
• Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats

  2019cites this paper
• Preclinical study on cardioprotective effect of ethanolic extract of Eucalyptus globulus against doxorubicin induced cardiotoxicity

  2018cites this paper
• Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity.

  2017cites this paper
• The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction

  2017cites this paper
• Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats

  2016cites this paper
• Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro.

  2015cites this paper
• The (un)SAFE and RISK(y) sides of doxorubicin-induced cardiotoxicity

  2014cites this paper
• Cardioprotective effect of ammonium glycyrrhizinate against doxorubicin-induced cardiomyopathy in experimental animals

  2014cites this paper
• New-Onset Congestive Heart Failure With Gemcitabine in Ovarian and Other Solid Cancers

  2014cites this paper
• Cardioprotective effect of Vedic Guard against doxorubicin-induced cardiotoxicity in rats: A biochemical, electrocardiographic, and histopathological study

  2013cites this paper
• Cardioprotective Activity of Fruit Extracts of Momordica Dioca Roxb. on Doxorubicin Induced Toxicity on Rats

  2013cites this paper
• Mechanisms of Cardiac Dysfunction Associated with Cancer Therapeutics

  2012cites this paper
• Cardiovascular Complications of Cancer Therapeutics

  2011cites this paper
• Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes

  2011cites this paper
• Mechanism of the cardioprotective effects of docetaxel pre-administration against adriamycin-induced cardiotoxicity.

  2011cites this paper
• Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity.

  2011cites this paper
• Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats.

  2010cites this paper
• Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity.

  2010cites this paper
• Cardiac specific transgenic inhibition of nuclear factor-kappaB (NF-kappaB) mitigates adverse cardiac remodeling and ameliorates cardiac dysfunction in doxorubicin-induced cardiomyopathy

  2010cites this paper
• Protective Effect of Solanum Torvum on Doxorubicin-Induced Cardiactoxicity in Rats

  2009cites this paper
• PROTECTIVE EFFECT OF EPHEDRA NEBRODENSIS ON DOXORUBICIN INDUCED CARDIOTOXICITY IN RATS

  2009cites this paper
• N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes

  2009cites this paper
• Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

  2009cites this paper
• Protective effect of Piper longum L. on oxidative stress induced injury and cellular abnormality in adriamycin induced cardiotoxicity in rats.

  2008cites this paper
• Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities.

  2007cites this paper
• Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.

  2007cites this paper
• New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.

  2006cites this paper
• Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.

  2006cites this paper
• Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity.

  2006cites this paper
• Evaluation of cardiac reserved function by high‐dose dobutamine‐stress echocardiography in asymptomatic anthracycline‐treated survivors of childhood cancer

  2006cites this paper
• Protective effect of CardiPro against doxorubicin-induced cardiotoxicity in mice.

  2006cites this paper
• Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment

  2005cites this paper
• Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity.

  2005cites this paper
• Modulation by Melatonin of the Cardiotoxic and Antitumor Activities of Adriamycin

  2005cites this paper
• Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit

  2004cites this paper
• Relative cardiotoxicity and cytotoxicity of anthraquinonyl glucosaminosides

  2004cites this paper
• Doxorubicin 투여 백서 심장의 심근과 신경 손상에 대한 Probucol과 Verapamil의 효과

  2004cites this paper
• Adriamycin Induced Apoptosis of H9c2 Cardiomyocytes via a Caspase-Independent Pathway

  2004cites this paper
• Telemetrically monitored arrhythmogenic effects of doxorubicin in a dog model of heart failure.

  2003cites this paper
• Structure and function of “metalloantibiotics”

  2003cites this paper
• Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes.

  2003cites this paper
• Doxorubicin-induced apoptosis: Implications in cardiotoxicity

  2002cites this paper
• Longitudinal evaluation of anthracycline cardiotoxicity by signal‐averaged electrocardiography in children with cancer

  2002cites this paper
• Antioxidant nutrients and adriamycin toxicity.

  2002cites this paper
• Serum Lipid and Fatty Acid Profiles in Adriamycin-Treated Rats after Administration of L-Carnitine

  2002cites this paper
• A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes.

  2001cites this paper
• Apoptosis in Adriamycin Cardiomyopathy and Its Modulation by Probucol

  2001cites this paper
• Adriamycin-induced heart failure: mechanisms and modulation

  2000cites this paper
• Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane.

  1999cites this paper
• Characterisation of a cellular model of cardiomyopathy, in the rabbit, produced by chronic administration of the anthracycline, epirubicin.

  1997cites this paper
• Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes.

  1997cites this paper
• Adriamycin cardiomyopathy: pathophysiology and prevention

  1997cites this paper
• Adriamycin depresses in vivo and in vitro phosphatidylethanolamine N-methylation in rat heart sarcolemma

  1997cites this paper
• Lipid lowering: an important factor in preventing adriamycin-induced heart failure.

  1997cites this paper
• The effects of adriamycin and adriamycin complexes with transitional metals on Ca(2+)-dependent K+ channels of human erythrocytes.

  1996cites this paper
• Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect.

  1995cites this paper
• Combination therapy with probucol prevents adriamycin-induced cardiomyopathy.

  1995cites this paper
• Effect of methotrexate, doxorubicin and mitoxantrone on human peritoneal mesothelial cell function in vitro.

  1995cites this paper
• Adriamycin Cardiomyopathy and Its Prevention in an Animal Model

  1995cites this paper
• Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.

  1994cites this paper
• Doxorubicin-induced changes in intracellular Ca2+ transients observed in cardiac myocytes isolated from guinea-pig heart.

  1994cites this paper
• Metabolic Effects of Chemotherapy on the Heart

  1993cites this paper
• Significance of adaptation mechanisms in adriamycin induced congestive heart failure

  1992cites this paper
• Doxorubicin: an antagonist of muscarinic receptors in guinea pig heart.

  1992cites this paper
• Etiology of sarcoplasmic reticulum calcium release channel lesions in doxorubicin-induced cardiomyopathy.

  1992cites this paper
• Adriamycin-induced changes to the myocardial beta-adrenergic system in the rabbit.

  1991cites this paper
• Protective effects of spin-trapping agents on adriamycin-induced cardiotoxicity in isolated rat atria.

  1991cites this paper
• Activity of receptors coupled to guanine nucleotide binding regulatory protein in doxorubicin induced cardiomyopathy.

  1991cites this paper
• On the Mechanism by Which Doxorubicin Abolishes the Oscillatory Events Induced by Ca Overload in Single Cardiac Myocytes

  1991cites this paper
• Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals.

  1991cites this paper
• Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats.

  1991cites this paper
• Doxorubicin cardiotoxicity: analysis of prevailing hypotheses

  1990cites this paper
• Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pump.

  1990cites this paper
• 31P and 13C NMR Studies of Acute and Chronic Adriamycin Cardiotoxicity

  1990cites this paper
• The relationship between cardiac function and metabolism in acute adriamycin-treated perfused rat hearts studied by 31P and 13C NMR spectroscopy.

  1990cites this paper
• Vitamin E deficiency accentuates adriamycin-induced cardiomyopathy and cell surface changes

  1988cites this paper
• INHIBITION OF α‐TOCOPHEROL AND CALCIUM CALMODULIN‐STIMULATED PHOSPHODIESTERASE ACTIVITY IN VITRO BY ANTHRACYCLINES

  1988cites this paper
• Effects of a Chronic Adriamycin Treatment of Rats on Myocardial Lipid Histochemistry

  1987cites this paper
• Exogenous doxorubicinol induces cardiotoxic effects in rats.

  1987cites this paper
• Subcellular effects of adriamycin in the heart: a concise review.

  1987cites this paper
• The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps. A correlative study of cardiac muscle with isolated membrane fractions.

  1987cites this paper
• Effect of daunorubicin on dihydropyridine-sensitive binding sites in cardiac sarcolemma.

  1987cites this paper
• General and cardiac toxicity of adriamycinol in rats.

  1986cites this paper
• Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function.

  1986cites this paper
• Adriamycin does have a potentially depressant effect on left ventricular contractility.

  1985cites this paper